Interact to see
Advertisement
Advertisement
FEFAX vs VIVIX
FEFAX vs VIVIX Comparison
Open Charts FEFAX vs VIVIX
First Eagle Rising Dividend Fund A
Price$27.43
Change+$0.20 (+0.73%)
VolumeN/A
Net Assets418.09M
Vanguard Value Index I
Price$68.94
Change+$0.24 (+0.35%)
VolumeN/A
Net Assets188.77B
FEFAX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FEFAX vs. VIVIX commentary
Jun 30, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEFAX is a Buy and VIVIX is a Buy.
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. FEFAX (418M). VIVIX pays higher dividends than FEFAX: VIVIX (2.29) vs FEFAX (0.93). FEFAX was incepted earlier than VIVIX: FEFAX (27 years) vs VIVIX (27 years). FEFAX (1.07) is less costly to investors than VIVIX (0.04). FEFAX is a more actively managed with annual turnover of: 15.44 vs. VIVIX (9.00). FEFAX has a lower initial minimum investment than VIVIX: FEFAX (2500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 10.60 vs. FEFAX (8.44). VIVIX return over 5 years is better than : 82.93 vs. FEFAX (16.52).
| FEFAX | VIVIX | FEFAX / VIVIX | |
| Total Expense Ratio | 0.90 | 0.04 | 2,250% |
| Annual Report Gross Expense Ratio | 1.07 | 0.04 | 2,675% |
| Fund Existence | 27 years | 27 years | - |
| Gain YTD | 8.174 | 4.436 | 184% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 418M | 189B | 0% |
| Annual Yield % from dividends | 0.93 | 2.29 | 41% |
| Returns for 1 year | 8.44 | 10.60 | 80% |
| Returns for 3 years | 36.65 | 33.29 | 110% |
| Returns for 5 years | 16.52 | 82.93 | 20% |
| Returns for 10 years | -24.69 | 112.46 | -22% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EIDIX | 18.10 | 0.12 | +0.67% |
| Eaton Vance Global Equity Income I | |||
| JVACX | 38.17 | 0.10 | +0.26% |
| JPMorgan Value Advantage C | |||
| LADPX | 20.34 | 0.05 | +0.25% |
| Lord Abbett Developing Growth P | |||
| PMIVX | 10.83 | 0.01 | +0.09% |
| Putnam Multi-Asset Income R6 | |||
| LYFAX | 12.14 | -0.02 | -0.16% |
| AlphaCentric Life Sciences & Hlthcare A | |||